Enterprise development blueprint
The cell medical industry business group is planned, with four core businesses as the main axis, and the ten-year plan for the three development stages is planned as the business goal design.
From 2020 to 2021
The first stage:
It will be the “basic stage”. Focusing on the construction of cell centers, integrated technology will produce a variety of mesenchymal stem cells, immune cells, and derived cell engineering. Will invest in the development of new drugs for clinical trials of cellular drugs, develop medical beauty care products and longevity maintenance kit products, establish global marketing channels, establish a Foresight R&D Foundation, and list companies on NASDAQ.
From 2022 to 2025
Iit will be a “growth stage”. With the goal of launching new drugs, through the five business centers in Taiwan, Hong Kong, Singapore, China, and the United States, a regional cell medical business group will be established with the new drug development plan. Continue to expand the cell center to establish a commissioned foundry mechanism and establish a cooperation mechanism with professional medical institutions. Continue to invest in research to establish core competitiveness with the foresight and derivative applications of cell medicine. Establish own
marketing system in the world, including online medical service platform, longevity tourism project cooperation, cell center, medical institution, agent etc.
From 2026 to 2030
The third stage:
It will be a “development stage” to build a longevity medical industry chain, including research institutions, cell factory medical materials business, medical institutions, and longevity nutrition industry. The big-health derived businesses include biochemical machinery, medical beauty, and cosmetics. Among them, medical institutions take cell medicine as the main axis to develop the longevity medical profession, and build an industrial integration platform of health inspection, medical treatment, health care, medical beauty, food and nutrition, body and mind. Core business entities continue to develop cell production and foundry businesses, and establish industrial mechanisms for research, production, and application division of labor.